ArticleFuture oncology (London, England)2024

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer.

Anwaar Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.